| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/30/2008 | CN101229277A Medicine compounds for treating leukemia |
| 07/30/2008 | CN101229229A Anticancer analgesic percutaneous absorption preparation |
| 07/30/2008 | CN101229227A Water aqua medicine compounds, preparing method and applications thereof |
| 07/30/2008 | CN101229215A Rhizoma bolbostemati crude extract component with liver cancer cells antigrowth effect and CDK1 kinase suppressive activity thereof |
| 07/30/2008 | CN101229214A Medical applications of stringy stonecrop ethamol soluble extractive |
| 07/30/2008 | CN101229213A Rhodiola rosea compound healthy product |
| 07/30/2008 | CN101229212A Lonicera fulvotnetosa total secondary saponin position, preparing method and antitumor uses thereof |
| 07/30/2008 | CN101229211A Broccoli seed extractive and preparing method thereof |
| 07/30/2008 | CN101229202A Brucea javanica oil lipidosome, freeze-dried powder preparation and preparing method thereof |
| 07/30/2008 | CN101229199A Integrative extract method of multi-active ingredient in cordyceps militaris mycelium |
| 07/30/2008 | CN101229184A Deoxyribonucleic retrogradation snippet compound and applications thereof |
| 07/30/2008 | CN101229183A Ribonucleic acid retrogradation snippet compound and applications thereof |
| 07/30/2008 | CN101229175A Medical applications of couple protopanoxadiol derivatives and compound body thereof |
| 07/30/2008 | CN101229168A Immunity excitant containing selenium |
| 07/30/2008 | CN101229167A Method of preparing sodium levofolinate and applications thereof on preparing tumour-curing medicines |
| 07/30/2008 | CN101229158A Medicine compounds for treating tumour and applications thereof |
| 07/30/2008 | CN101229151A Oridonin medicine-loading nano particle freeze-dried powder injection and preparing method thereof |
| 07/30/2008 | CN101229150A Thermostatic sustained release injection containing taxane and preparing method thereof |
| 07/30/2008 | CN101229135A Injectio natarii norcantharidatis freeze-dried powder for injection and preparing method thereof |
| 07/30/2008 | CN101229131A Novel type nanometer particle preparation capable of reducing gastroenteritic toxicity of camptothecin medicines |
| 07/30/2008 | CN101229130A Isomorellic acid polylactic acid nano particle preparation and preparing method thereof |
| 07/30/2008 | CN101229127A Liposome preparation |
| 07/30/2008 | CN101229125A Microemulsion injection containing injectio natarii norcantharidatis |
| 07/30/2008 | CN101229120A Sustained release implant for treating solid tumors |
| 07/30/2008 | CN101229119A Sustained release ocular implant for treating solid tumors |
| 07/30/2008 | CN101229118A Thermostatic sustained release injection containing topoisomerase inhibitor and preparing method thereof |
| 07/30/2008 | CN101229117A Thermostatic sustained release injection containing phosphatidylinositol 3-genistein inhibitor and preparing method thereof |
| 07/30/2008 | CN100406891C 利用EPF受体鉴定结合或调节hDRR活性的化合物以及hDRR的分离 Identification of isolated compounds utilizing EPF receptor binding or regulate the activity and hDRR of hDRR |
| 07/30/2008 | CN100406465C Anthraquinone glycoside compounds containing glucopyranoside group and use thereof |
| 07/30/2008 | CN100406461C Sulphur containing heterocyclic and naphthalimides compound and use thereof |
| 07/30/2008 | CN100406460C Novel derivative of camptothecine, preparing method and use |
| 07/30/2008 | CN100406459C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 07/30/2008 | CN100406458C Novel heterocycle naphthoylimine and double-chain compound and its uses in tumour cell |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406453C 4-anilino-quinazoline derivatives as antiproliferative agents |
| 07/30/2008 | CN100406452C N-phenyl-2-pyrimidine-amine derivatives |
| 07/30/2008 | CN100406449C CDC25 phosphatase inhibitors |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406065C Conjugates of glycosylated/galactosylated peptide, bifunctional linker and nucleotidic monomers/polymers, and related compositions and method of use |
| 07/30/2008 | CN100406061C Use of regulating T-cell loss agent in preparing medicament |
| 07/30/2008 | CN100406060C Adjuvant composition |
| 07/30/2008 | CN100406057C Amelioration of effects of cigarette smoke |
| 07/30/2008 | CN100406041C Chinese herbal medicine prescription for treating cancer |
| 07/30/2008 | CN100406037C Heterocarpin, a plant-derived protein with anti-cancer properties |
| 07/30/2008 | CN100406026C Medicine for treating chronic gastritis and gastric carcinoma, and its preparing method |
| 07/30/2008 | CN100406023C Apoptosis inducers |
| 07/30/2008 | CN100406016C Combinations of a cathepsin K inhibitor and a bisphophonate in the treatment of bone metastasis tumor, tumor growth and tumor-induced bone loss |
| 07/30/2008 | CN100406013C Camptothecin derivatives |
| 07/30/2008 | CN100406010C Antitumor agents and process for producing the same |
| 07/30/2008 | CN100406006C Chromatosis remedies |
| 07/30/2008 | CA2619799A1 Methods for evaluating and implementing prostate disease treatments |
| 07/29/2008 | US7405306 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 07/29/2008 | US7405299 Compounds as pharmaceutical agents |
| 07/29/2008 | US7405274 Monoclonal antibodies for use in diagnosis and treatment of diabetes, hypertension, hyperglycemia and congestive heart failure |
| 07/29/2008 | US7405233 e.g. 3-[3-(4-ISOPROPYLPHENYL)-2,5-DIOXO-IMIDAZOLIDIN-1-YL]-BENZOIC ACID SODIUM SALT; method of modulating premature translation termination and/or nonsense-mediated mRNA decay in a cell in vitro; cystic fibrosis or Duchenne muscular dystrophy |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/29/2008 | US7405218 Isothiazole derivatives useful as anticancer agents |
| 07/29/2008 | US7405213 such as 3-chloro-4-fluoro-N-(5-{[6-({3-[4-(hydroxymethyl)piperidin-1-yl]propyl}oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino}pyrimidin-2-yl)benzamide; serine/threonine Aurora kinase inhibitor; anticarcinogenic agent |
| 07/29/2008 | US7405211 Therapeutic morpholino-substituted compounds |
| 07/29/2008 | US7405205 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| 07/29/2008 | US7405200 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 07/29/2008 | US7405194 Therapeutic agents and methods of use thereof for the treatment of melanoma |
| 07/29/2008 | US7405060 Gene amplification methods |
| 07/29/2008 | US7405058 Thymic stromal lymphopoietin (TSLP); nucleic acid encoding polypeptide of given sequence; use in peptide fragmentation studies and molecular weight measurements |
| 07/29/2008 | US7405045 Retrieving ductal fluid samples from ducts using elongated lumen and detecting presence of papilloma, Epstein-barr and herpes virus |
| 07/29/2008 | US7404973 For use as dietary supplement, in drugs, soy protein concentrate |
| 07/29/2008 | US7404952 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 07/29/2008 | US7404270 Tumor antigen |
| 07/29/2008 | CA2460939C Substituted pyrazolyl compounds for the treatment of inflammation |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/29/2008 | CA2352149C Solid lipidic nanospheres suitable to a fast internalization into cells |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2337755C Inhibitors of p38 |
| 07/29/2008 | CA2333656C A novel vla-4 inhibitor: omepupa-v |
| 07/29/2008 | CA2333008C New heterocyclically substituted amides, their production and their use |
| 07/29/2008 | CA2324077C Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 07/29/2008 | CA2307002C Antitumour uridine analogues |
| 07/29/2008 | CA2284653C Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 07/29/2008 | CA2250141C Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 07/29/2008 | CA2214086C Pyrazole derivatives and processes for the preparation thereof |
| 07/29/2008 | CA2175767C Adhesion receptor antagonists |
| 07/24/2008 | WO2008089478A2 Thermotherapy susceptors and methods of using same |
| 07/24/2008 | WO2008089459A1 Inhibitors of mek |
| 07/24/2008 | WO2008089390A1 New classical antifolates |
| 07/24/2008 | WO2008089389A2 Treatment of cancers with acquired resistance to kit inhibitors |
| 07/24/2008 | WO2008089388A2 Treatment of cancers having resistance to chemotherapeutic agents |
| 07/24/2008 | WO2008089272A1 Formulations for cancer treatment |
| 07/24/2008 | WO2008089105A2 Antiviral nucleoside analogs |
| 07/24/2008 | WO2008088779A2 Solid state forms of 5-azacytidine and processes for preparation thereof |
| 07/24/2008 | WO2008088583A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 07/24/2008 | WO2008088548A2 Disintegrin variants and pharmaceutical uses thereof |
| 07/24/2008 | WO2008088088A1 Composition for treatment of pancreatic cancer |
| 07/24/2008 | WO2008088047A1 Method for glycosylation of flavonoid |
| 07/24/2008 | WO2008088006A1 Ap2 inhibitor |
| 07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |